Davita - Mid Ohio Dialysis is a medicare approved dialysis facility center in Mansfield, Ohio and it has 13 dialysis stations. It is located in Richland county at 2148 W 4th St, Mansfield, OH, 44906. You can reach out to the office of Davita - Mid Ohio Dialysis at (419) 747-4039. This dialysis clinic is managed and/or owned by Davita. Davita - Mid Ohio Dialysis has the following ownership type - Profit. It was first certified by medicare in December, 2013. The medicare id for this facility is 362804 and it accepts patients under medicare ESRD program.
| Name | Davita - Mid Ohio Dialysis |
|---|---|
| Location | 2148 W 4th St, Mansfield, Ohio |
| No. of Dialysis Stations | 13 |
| Medicare ID | 362804 |
| Managed By | Davita |
| Ownership Type | Profit |
| Late Shifts | No |
| 2148 W 4th St, Mansfield, Ohio, 44906 | |
| (419) 747-4039 | |
News Archive
Sphere Medical, innovator in critical care monitoring and diagnostics equipment, will launch its cutting edge in-line patient dedicated arterial blood gas analyser at the AAGBI Annual Congress 2014, Harrogate, 17-19th September.
BioPharmX Corporation, a biotechnology company focused on the development of novel drug delivery products to address unmet needs in large, well-defined and underserved markets, today announced that it has submitted a request for a pre-IND (Investigational New Drug) meeting to the U.S. Food and Drug Administration for the company's topical antibiotic acne compound currently under development.
Medicare's new private stand-alone drug plans vary significantly - in terms of covered drugs, out-of-pocket costs for specific medications, and restrictions placed on the use of certain drugs - according to a new analysis released today by the Kaiser Family Foundation.
A Mount Sinai Medical Center study has found that lower frequency deep brain stimulation in young patients with primary torsion dystonia is as effective as higher frequency stimulation, which has been commonly used.
› Verified 5 days ago
| NPI Number | 1023360955 |
| Organization Name | Mid Ohio Dialysis |
| Doing Business As | Wallowa Dialysis Llc |
| Address | 2148 W 4th St Ontario, Ohio, 44906 |
| Phone Number | (419) 747-4039 |
News Archive
Sphere Medical, innovator in critical care monitoring and diagnostics equipment, will launch its cutting edge in-line patient dedicated arterial blood gas analyser at the AAGBI Annual Congress 2014, Harrogate, 17-19th September.
BioPharmX Corporation, a biotechnology company focused on the development of novel drug delivery products to address unmet needs in large, well-defined and underserved markets, today announced that it has submitted a request for a pre-IND (Investigational New Drug) meeting to the U.S. Food and Drug Administration for the company's topical antibiotic acne compound currently under development.
Medicare's new private stand-alone drug plans vary significantly - in terms of covered drugs, out-of-pocket costs for specific medications, and restrictions placed on the use of certain drugs - according to a new analysis released today by the Kaiser Family Foundation.
A Mount Sinai Medical Center study has found that lower frequency deep brain stimulation in young patients with primary torsion dystonia is as effective as higher frequency stimulation, which has been commonly used.
› Verified 5 days ago
| Dialysis patients with Hemoglobin data | 18 |
News Archive
Sphere Medical, innovator in critical care monitoring and diagnostics equipment, will launch its cutting edge in-line patient dedicated arterial blood gas analyser at the AAGBI Annual Congress 2014, Harrogate, 17-19th September.
BioPharmX Corporation, a biotechnology company focused on the development of novel drug delivery products to address unmet needs in large, well-defined and underserved markets, today announced that it has submitted a request for a pre-IND (Investigational New Drug) meeting to the U.S. Food and Drug Administration for the company's topical antibiotic acne compound currently under development.
Medicare's new private stand-alone drug plans vary significantly - in terms of covered drugs, out-of-pocket costs for specific medications, and restrictions placed on the use of certain drugs - according to a new analysis released today by the Kaiser Family Foundation.
A Mount Sinai Medical Center study has found that lower frequency deep brain stimulation in young patients with primary torsion dystonia is as effective as higher frequency stimulation, which has been commonly used.
› Verified 5 days ago
Adult patinets who undergo hemodialysis, their Kt/V should be atleast 1.2 and for peritoneal dialysis the Kt/V should be atleast 1.7, that means they are receiving right amount of dialysis. Pediatric patients who undergo hemodialysis, their Kt/V should be atleast 1.2 and for peritoneal dialysis the Kt/V should be 1.8.
Higher percentages should be better.
| Adult patients getting regular hemodialysis at the center | 32 |
| Adult patient months included in Kt/V greater than or equal to 1.2 | 259 |
| Percentage of adult patients getting regular hemodialysis at the center | 99 |
| Percentage of pediatric patients getting regular hemodialysis at the center |
News Archive
Sphere Medical, innovator in critical care monitoring and diagnostics equipment, will launch its cutting edge in-line patient dedicated arterial blood gas analyser at the AAGBI Annual Congress 2014, Harrogate, 17-19th September.
BioPharmX Corporation, a biotechnology company focused on the development of novel drug delivery products to address unmet needs in large, well-defined and underserved markets, today announced that it has submitted a request for a pre-IND (Investigational New Drug) meeting to the U.S. Food and Drug Administration for the company's topical antibiotic acne compound currently under development.
Medicare's new private stand-alone drug plans vary significantly - in terms of covered drugs, out-of-pocket costs for specific medications, and restrictions placed on the use of certain drugs - according to a new analysis released today by the Kaiser Family Foundation.
A Mount Sinai Medical Center study has found that lower frequency deep brain stimulation in young patients with primary torsion dystonia is as effective as higher frequency stimulation, which has been commonly used.
› Verified 5 days ago
| Adult patients getting regular peritoneal dialysis at the center | 1 |
| Adult patient months included in Kt/V greater than or equal to 1.7 | 12 |
| Percentage of adult patients getting regular peritoneal dialysis at the center | |
| Percentage of pediatric patients getting regular peritoneal dialysis at the center |
News Archive
Sphere Medical, innovator in critical care monitoring and diagnostics equipment, will launch its cutting edge in-line patient dedicated arterial blood gas analyser at the AAGBI Annual Congress 2014, Harrogate, 17-19th September.
BioPharmX Corporation, a biotechnology company focused on the development of novel drug delivery products to address unmet needs in large, well-defined and underserved markets, today announced that it has submitted a request for a pre-IND (Investigational New Drug) meeting to the U.S. Food and Drug Administration for the company's topical antibiotic acne compound currently under development.
Medicare's new private stand-alone drug plans vary significantly - in terms of covered drugs, out-of-pocket costs for specific medications, and restrictions placed on the use of certain drugs - according to a new analysis released today by the Kaiser Family Foundation.
A Mount Sinai Medical Center study has found that lower frequency deep brain stimulation in young patients with primary torsion dystonia is as effective as higher frequency stimulation, which has been commonly used.
› Verified 5 days ago
An important goal of dialysis is to maintain normal levels of various minerals in the body, such as calcium. This shows the percentage of patients treated at Davita - Mid Ohio Dialysis with elevated calcium levels.
| Patients with hypercalcemia | 33 |
| Hypercalcemia patient months | 274 |
| Patients with Serumphosphor | 34 |
| Patients with Serumphosphor less than 3.5 mg/dL | 7 |
| Patients with Serumphosphor from 3.5 to 4.5 mg/dL | 25 |
| Patients with Serumphosphor from 4.6 to 5.5 mg/dL | 35 |
| Patients with Serumphosphor from 5.6 to 7 mg/dL | 18 |
| Patients with Serumphosphor greater than 7 mg/dL | 15 |
News Archive
Sphere Medical, innovator in critical care monitoring and diagnostics equipment, will launch its cutting edge in-line patient dedicated arterial blood gas analyser at the AAGBI Annual Congress 2014, Harrogate, 17-19th September.
BioPharmX Corporation, a biotechnology company focused on the development of novel drug delivery products to address unmet needs in large, well-defined and underserved markets, today announced that it has submitted a request for a pre-IND (Investigational New Drug) meeting to the U.S. Food and Drug Administration for the company's topical antibiotic acne compound currently under development.
Medicare's new private stand-alone drug plans vary significantly - in terms of covered drugs, out-of-pocket costs for specific medications, and restrictions placed on the use of certain drugs - according to a new analysis released today by the Kaiser Family Foundation.
A Mount Sinai Medical Center study has found that lower frequency deep brain stimulation in young patients with primary torsion dystonia is as effective as higher frequency stimulation, which has been commonly used.
› Verified 5 days ago
The arteriovenous (AV) fistulae is considered long term vascular access for hemodialysis because it allows good blood flow, lasts a long time, and is less likely to get infected or cause blood clots than other types of access. Patients who don't have time to get a permanent vascular access before they start hemodialysis treatments may need to use a venous catheter as a temporary access.
| Patients included in arterial venous fistula and catheter summaries | 29 |
| Patient months included in arterial venous fistula and catheter summaries | 210 |
| Percentage of patients getting regular hemodialysis at the center that used an arteriovenous (AV) fistulae for their treatment | 83 |
| Percentage of patients receiving treatment through Vascular Catheter for 90 days/longer | 3 |
News Archive
Sphere Medical, innovator in critical care monitoring and diagnostics equipment, will launch its cutting edge in-line patient dedicated arterial blood gas analyser at the AAGBI Annual Congress 2014, Harrogate, 17-19th September.
BioPharmX Corporation, a biotechnology company focused on the development of novel drug delivery products to address unmet needs in large, well-defined and underserved markets, today announced that it has submitted a request for a pre-IND (Investigational New Drug) meeting to the U.S. Food and Drug Administration for the company's topical antibiotic acne compound currently under development.
Medicare's new private stand-alone drug plans vary significantly - in terms of covered drugs, out-of-pocket costs for specific medications, and restrictions placed on the use of certain drugs - according to a new analysis released today by the Kaiser Family Foundation.
A Mount Sinai Medical Center study has found that lower frequency deep brain stimulation in young patients with primary torsion dystonia is as effective as higher frequency stimulation, which has been commonly used.
› Verified 5 days ago
The rate of hospitalization show you whether patients who were being treated regularly at a certain dialysis center were admitted to the hospital more often (worse than expected), less often (better than expected), or about the same (as expected), compared to similar patients treated at other centers.
| Standard Hospitalization Summary Ratio(SHR) Year | January, 2016 - December, 2016 |
| Patients in facility's Hospitalization Summary | 21 |
| Hospitalization Rate in facility | 127 (As Expected) |
| Hospitalization Rate: Upper Confidence Limit | 381.7 |
| Hospitalization Rate: Lower Confidence Limit | 46.1 |
News Archive
Sphere Medical, innovator in critical care monitoring and diagnostics equipment, will launch its cutting edge in-line patient dedicated arterial blood gas analyser at the AAGBI Annual Congress 2014, Harrogate, 17-19th September.
BioPharmX Corporation, a biotechnology company focused on the development of novel drug delivery products to address unmet needs in large, well-defined and underserved markets, today announced that it has submitted a request for a pre-IND (Investigational New Drug) meeting to the U.S. Food and Drug Administration for the company's topical antibiotic acne compound currently under development.
Medicare's new private stand-alone drug plans vary significantly - in terms of covered drugs, out-of-pocket costs for specific medications, and restrictions placed on the use of certain drugs - according to a new analysis released today by the Kaiser Family Foundation.
A Mount Sinai Medical Center study has found that lower frequency deep brain stimulation in young patients with primary torsion dystonia is as effective as higher frequency stimulation, which has been commonly used.
› Verified 5 days ago
The rate of readmission show you whether patients who were being treated regularly at Davita - Mid Ohio Dialysis were readmitted more often (worse than expected), less often (better than expected), or about the same (as expected), compared to similar patients treated at other dialysis centers.
| Standard Readmission Summary Ratio(SRR) Year | January, 2016 - December, 2016 |
| Readmission Rate in facility | 23 (As Expected) |
| Readmission Rate: Upper Confidence Limit | 46.7 |
| Readmission Rate: Lower Confidence Limit | 7.3 |
News Archive
Sphere Medical, innovator in critical care monitoring and diagnostics equipment, will launch its cutting edge in-line patient dedicated arterial blood gas analyser at the AAGBI Annual Congress 2014, Harrogate, 17-19th September.
BioPharmX Corporation, a biotechnology company focused on the development of novel drug delivery products to address unmet needs in large, well-defined and underserved markets, today announced that it has submitted a request for a pre-IND (Investigational New Drug) meeting to the U.S. Food and Drug Administration for the company's topical antibiotic acne compound currently under development.
Medicare's new private stand-alone drug plans vary significantly - in terms of covered drugs, out-of-pocket costs for specific medications, and restrictions placed on the use of certain drugs - according to a new analysis released today by the Kaiser Family Foundation.
A Mount Sinai Medical Center study has found that lower frequency deep brain stimulation in young patients with primary torsion dystonia is as effective as higher frequency stimulation, which has been commonly used.
› Verified 5 days ago
Hemodialysis treatment requires direct access to the bloodstream, which can be an opportunity for germs to enter the body and cause infection. This information shows how often patients at Davita - Mid Ohio Dialysis get infections in their blood each year compared to the number of infections expected for the center based on the national average.
| Standard Infection Summary Ratio(SIR) Year | January, 2016 - December, 2016 |
| Infection Rate in facility | 2.48 (As Expected) |
| SIR: Upper Confidence Limit | 8.19 |
| SIR: Lower Confidence Limit | .42 |
News Archive
Sphere Medical, innovator in critical care monitoring and diagnostics equipment, will launch its cutting edge in-line patient dedicated arterial blood gas analyser at the AAGBI Annual Congress 2014, Harrogate, 17-19th September.
BioPharmX Corporation, a biotechnology company focused on the development of novel drug delivery products to address unmet needs in large, well-defined and underserved markets, today announced that it has submitted a request for a pre-IND (Investigational New Drug) meeting to the U.S. Food and Drug Administration for the company's topical antibiotic acne compound currently under development.
Medicare's new private stand-alone drug plans vary significantly - in terms of covered drugs, out-of-pocket costs for specific medications, and restrictions placed on the use of certain drugs - according to a new analysis released today by the Kaiser Family Foundation.
A Mount Sinai Medical Center study has found that lower frequency deep brain stimulation in young patients with primary torsion dystonia is as effective as higher frequency stimulation, which has been commonly used.
› Verified 5 days ago
Patients with anemia require blood transfusions if their anemia is not managed well by their dialysis center. This information shows whether Davita - Mid Ohio Dialysis's rate of transfusions is better than expected, as expected, or worse than expected, compared to other centers that treat similar patients.
| Standard Transfusion Summary Ratio (STrR) Year | January, 2016 - December, 2016 |
| Patients in facility's Transfusion Summary | 17 |
| Transfusion Rate in facility | (Not Available) |
| Transfusion Rate: Upper Confidence Limit | |
| Transfusion Rate: Lower Confidence Limit |
News Archive
Sphere Medical, innovator in critical care monitoring and diagnostics equipment, will launch its cutting edge in-line patient dedicated arterial blood gas analyser at the AAGBI Annual Congress 2014, Harrogate, 17-19th September.
BioPharmX Corporation, a biotechnology company focused on the development of novel drug delivery products to address unmet needs in large, well-defined and underserved markets, today announced that it has submitted a request for a pre-IND (Investigational New Drug) meeting to the U.S. Food and Drug Administration for the company's topical antibiotic acne compound currently under development.
Medicare's new private stand-alone drug plans vary significantly - in terms of covered drugs, out-of-pocket costs for specific medications, and restrictions placed on the use of certain drugs - according to a new analysis released today by the Kaiser Family Foundation.
A Mount Sinai Medical Center study has found that lower frequency deep brain stimulation in young patients with primary torsion dystonia is as effective as higher frequency stimulation, which has been commonly used.
› Verified 5 days ago
The rate of mortality show you whether patients who were being treated regularly at Davita - Mid Ohio Dialysis lived longer than expected (better than expected), don’t live as long as expected (worse than expected), or lived as long as expected (as expected), compared to similar patients treated at other facilities.
| Standard Survival Summary Ratio(SIR) Year | January, 2013 - December, 2016 |
| Patients in facility's Survival Summary | 74 |
| Mortality Rate in facility | 18.5 (As Expected) |
| Mortality Rate: Upper Confidence Limit | 38.1 |
| Mortality Rate: Lower Confidence Limit | 7.4 |
News Archive
Sphere Medical, innovator in critical care monitoring and diagnostics equipment, will launch its cutting edge in-line patient dedicated arterial blood gas analyser at the AAGBI Annual Congress 2014, Harrogate, 17-19th September.
BioPharmX Corporation, a biotechnology company focused on the development of novel drug delivery products to address unmet needs in large, well-defined and underserved markets, today announced that it has submitted a request for a pre-IND (Investigational New Drug) meeting to the U.S. Food and Drug Administration for the company's topical antibiotic acne compound currently under development.
Medicare's new private stand-alone drug plans vary significantly - in terms of covered drugs, out-of-pocket costs for specific medications, and restrictions placed on the use of certain drugs - according to a new analysis released today by the Kaiser Family Foundation.
A Mount Sinai Medical Center study has found that lower frequency deep brain stimulation in young patients with primary torsion dystonia is as effective as higher frequency stimulation, which has been commonly used.
› Verified 5 days ago
News Archive
Sphere Medical, innovator in critical care monitoring and diagnostics equipment, will launch its cutting edge in-line patient dedicated arterial blood gas analyser at the AAGBI Annual Congress 2014, Harrogate, 17-19th September.
BioPharmX Corporation, a biotechnology company focused on the development of novel drug delivery products to address unmet needs in large, well-defined and underserved markets, today announced that it has submitted a request for a pre-IND (Investigational New Drug) meeting to the U.S. Food and Drug Administration for the company's topical antibiotic acne compound currently under development.
Medicare's new private stand-alone drug plans vary significantly - in terms of covered drugs, out-of-pocket costs for specific medications, and restrictions placed on the use of certain drugs - according to a new analysis released today by the Kaiser Family Foundation.
A Mount Sinai Medical Center study has found that lower frequency deep brain stimulation in young patients with primary torsion dystonia is as effective as higher frequency stimulation, which has been commonly used.
› Verified 5 days ago